Usage, Risk, and Benefit of Weight-Loss Drugs in Primary Care

Purpose. To investigate the use of the weight-loss drugs rimonabant, sibutramine, and orlistat in primary care and to characterize the patients receiving the drugs. Methods. In this retrospective, descriptive study, 300 randomly selected patients having started weight-loss drug treatment at 15 prima...

Descripción completa

Detalles Bibliográficos
Autores principales: Forslund, Tomas, Raaschou, Pauline, Hjemdahl, Paul, Krakau, Ingvar, Wettermark, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139204/
https://www.ncbi.nlm.nih.gov/pubmed/21785716
http://dx.doi.org/10.1155/2011/459263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3139204/
https://www.ncbi.nlm.nih.gov/pubmed/21785716
http://dx.doi.org/10.1155/2011/459263

Ejemplares similares